Medtronic plc (MDT) operating KPIs
MDTNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends April 24
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 3, 2026Score 19/303% below fair value
$96.54−0.57 (-0.59%)
Close on Oct 30, 2026Market cap $123.49BP/E 23.7Yield 2.94%
Medtronic neuroscience — Segment Depreciation Expense ($M) ($M)
Annual figures from Medtronic's filings and investor materials
Latest, FY2026
320
Period ended Apr 30, 2026
Change on a year earlier
+13.5%
282 in FY2025
History
8 years
Since FY2019
Sources
6
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Neuroscience — Segment Depreciation Expense ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2026 | Apr 30, 2026 | 320 | +13.5% | Medtronic Form 10-K — FY2026 (filed 2026-06-18) ↗ |
| FY2025 | Apr 30, 2025 | 282 | +11.9% | Medtronic Form 10-K — FY2026 (filed 2026-06-18) ↗ |
| FY2024 | Apr 30, 2024 | 252 | -5.6% | Medtronic Form 10-K — FY2026 (filed 2026-06-18) ↗ |
| FY2023 | Apr 30, 2023 | 267 | +0.8% | Medtronic Form 10-K — FY2025 (filed 2025-06-20) ↗ |
| FY2022 | Apr 30, 2022 | 265 | +12.3% | Medtronic Form 10-K — FY2024 (filed 2024-06-20) ↗ |
| FY2021 | Apr 30, 2021 | 236 | +1.3% | Medtronic Form 10-K — FY2023 (filed 2023-06-22) ↗ |
| FY2020 | Apr 30, 2020 | 233 | +7.4% | Medtronic Form 10-K — FY2022 (filed 2022-06-23) ↗ |
| FY2019 | Apr 30, 2019 | 217 | – | Medtronic Form 10-K — FY2021 (filed 2021-06-25) ↗ |
Cite this data
StockData. (2026). Medtronic Neuroscience — Segment Depreciation Expense ($M) ($M), annual FY2019–FY2026 [Data set]. Compiled from Medtronic SEC filings and investor materials. https://stockdatahq.com/stocks/mdt/kpis/seg-depr-neuro
See every metric in the Medtronic KPI table. Data updated Oct 31, 2026.